HW-165

N/A

Report date: 2025/02/07 11:37:37

Base Information

Drug NameHW-165

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine receptors agonists

TargetsDopamine receptors

Therapy Area/IndicationsSchizophreniaParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsSchizophreniaParkinson Disease

ATC CodeN/A